4//SEC Filing
Pano Arian 4
Accession 0001179110-21-008655
CIK 0001730430other
Filed
Sep 6, 8:00 PM ET
Accepted
Sep 7, 5:19 PM ET
Size
7.8 KB
Accession
0001179110-21-008655
Insider Transaction Report
Form 4
Pano Arian
Chief Clinical Dev. Officer
Transactions
- Award
Restricted Share Units
2021-09-02+3,888→ 3,888 total→ Class A Common Shares (3,888 underlying) - Award
Share Option
2021-09-02+23,325→ 23,325 totalExercise: $12.97Exp: 2031-09-01→ Class A Common Shares (23,325 underlying)
Footnotes (3)
- [F1]The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 2, 2021.
- [F2]Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.
- [F3]The Restricted Share Units (RSUs) vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 2, 2021.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001867891
Filing Metadata
- Form type
- 4
- Filed
- Sep 6, 8:00 PM ET
- Accepted
- Sep 7, 5:19 PM ET
- Size
- 7.8 KB